19-50856309-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001648.2(KLK3):c.116A>T(p.Gln39Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000736 in 1,613,540 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00079 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 18 hom. )
Consequence
KLK3
NM_001648.2 missense
NM_001648.2 missense
Scores
1
2
5
Clinical Significance
Conservation
PhyloP100: 0.990
Genes affected
KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.234455).
BP6
Variant 19-50856309-A-T is Benign according to our data. Variant chr19-50856309-A-T is described in ClinVar as [Benign]. Clinvar id is 778603.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.00073 (1066/1461254) while in subpopulation AMR AF= 0.0232 (1038/44718). AF 95% confidence interval is 0.022. There are 18 homozygotes in gnomad4_exome. There are 420 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 18 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK3 | NM_001648.2 | c.116A>T | p.Gln39Leu | missense_variant | 2/5 | ENST00000326003.7 | NP_001639.1 | |
KLK3 | NM_001030047.1 | c.116A>T | p.Gln39Leu | missense_variant | 2/5 | NP_001025218.1 | ||
KLK3 | NM_001030048.1 | c.116A>T | p.Gln39Leu | missense_variant | 2/5 | NP_001025219.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLK3 | ENST00000326003.7 | c.116A>T | p.Gln39Leu | missense_variant | 2/5 | 1 | NM_001648.2 | ENSP00000314151.1 |
Frequencies
GnomAD3 genomes AF: 0.000795 AC: 121AN: 152168Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
121
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00366 AC: 920AN: 251380Hom.: 16 AF XY: 0.00263 AC XY: 357AN XY: 135858
GnomAD3 exomes
AF:
AC:
920
AN:
251380
Hom.:
AF XY:
AC XY:
357
AN XY:
135858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000730 AC: 1066AN: 1461254Hom.: 18 Cov.: 32 AF XY: 0.000578 AC XY: 420AN XY: 726932
GnomAD4 exome
AF:
AC:
1066
AN:
1461254
Hom.:
Cov.:
32
AF XY:
AC XY:
420
AN XY:
726932
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000795 AC: 121AN: 152286Hom.: 1 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74458
GnomAD4 genome
AF:
AC:
121
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
54
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
331
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 22, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
ClinPred
T
GERP RS
La Branchor
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at